Core Insights - KINGSONG has launched four next-generation electric unicycles, marking a significant upgrade in their product lineup and advancing their vision of intelligent mobility [1][3][22] Product Development and Innovation - With 17 years of innovation, KINGSONG has established a fully integrated product development ecosystem, controlling the entire process from design to manufacturing, which sets a new industry standard for smart mobility solutions [2][22] - The new models—14D Pro, 16S Pro, 16X Pro, and 18XL Pro—feature advancements in power, range, intelligence, and safety, catering to various skill levels and enhancing urban commuting and long-distance travel [3][4][8] Model Specifications - **Kingsong 16S Pro**: Features a 3800W motor, top speed of 40 km/h, 35° climbing capability, and a real-world range of up to 80 km [4][5] - **Kingsong 16X Pro**: Equipped with a 4600W motor, top speed of 60 km/h, and a real-world range of up to 160 km, with a fast-charging system that reaches full capacity in 2.5 hours [8][9][10] - **Kingsong 14D Pro**: Offers a 2000W peak motor, top speed of 30 km/h, and a real-world range of up to 40 km, with fast charging in 2 hours [13][15] - **Kingsong 18XL Pro**: Features a 4600W motor, top speed of 60 km/h, and a range of up to 140 km, designed for both beginners and experienced riders [16][17] Marketing and Promotions - KINGSONG is running a Black Friday promotion with tiered savings for customers, offering discounts based on purchase amounts and additional loyalty discounts for early orders [19][20] - The promotion emphasizes the company's commitment to innovation and the future of smart mobility, encouraging customers to experience their advanced products [20][22] Company Overview - Founded in 2012, KINGSONG operates a state-of-the-art facility and manages the full value chain from design to international sales, ensuring high-quality products [22][25] - The company holds over 100 patents and continues to expand its product portfolio to cater to diverse mobility needs, including electric unicycles, e-scooters, and smart vehicles for various age groups [23][24]

Core Insights - The 2025 Classical Chinese Poetry Contest aims to foster cultural dialogue between the East and West through poetry [1][7] - The program has evolved into a flagship cultural initiative in China since its inception in 2016, blending classical poetry with modern competitive formats [3][4] - The contest celebrates its 10th anniversary by featuring diverse contestants and showcasing the relevance of classical poetry in contemporary society [4] Program Features - The 2025 edition introduces AI-generated imagery and advanced lighting technology to enhance visual storytelling and revive classical motifs [5] - A refreshed format includes beloved segments and new challenges, such as the "Champions' League" and a situational challenge inspired by classical art [6] - Esteemed cultural scholars will provide commentary to guide audiences through the emotional and spiritual aspects of Chinese poetry [4][6] Cultural Significance - The contest serves as a cultural anchor for overseas Chinese and provides European audiences with insights into the linguistic artistry and philosophical depth of Chinese poetry [7]

Core Insights - Hotel101 Global Holdings Corp. is expanding its presence in Europe with a new 429-room hotel in San Donato Milanese, Milan, Italy, marking a significant milestone in its growth strategy [3][6] - The hotel is projected to generate approximately EUR 85.8 million in sales revenue, contributing to the company's global expansion efforts [6][10] - The development aligns with Hotel101's commitment to sustainable urban hospitality, incorporating energy-efficient designs and community-integrated amenities [8] Location Advantages - The hotel is strategically located about 7.1 kilometers from Linate Airport, providing quick access for travelers [5] - It is approximately 4 kilometers from the Metro Milano San Donato, allowing guests to reach central Milan in about 12 minutes [5] - The site is situated in a vibrant community with high visibility along the Autostrada del Sole, enhancing its appeal to both leisure and business travelers [4][5] Project Details - The hotel will occupy a 1.4-hectare prime site and is expected to be one of the top three largest hotels in Milan by room count [1][3] - Hotel101-Milan is anticipated to be completed by 2028 and will offer 4-star amenities at affordable prices [7][6] - The project is part of a broader strategy that includes developments in Niseko, Japan, Madrid, Spain, and Los Angeles, USA [6][11] Business Model - Hotel101 operates under a unique asset-light, prop-tech hospitality model, allowing it to generate revenue from both the advance sale of hotel units and ongoing hotel operations [10][12] - The company aims to disrupt the hospitality sector with its globally standardized "condotel" business model [10] - Hotel101 aspires to operate 1 million rooms across 100 countries, with a focus on expanding its footprint in priority markets [11][12]

Core Insights - Maase Inc. has appointed Mr. Jingkai Li as the new chairman of the board, succeeding Ms. Hong Suong Nguyen, effective November 28, 2025 [1][2][3] Company Overview - Maase Inc. was founded in 2010 and has evolved from being known as Highest Performances Holdings Inc. and Puyi Inc. to a provider of intelligent technology-driven family and enterprise services [4] - The company's mission focuses on enhancing the quality of life for families globally through technological intelligence and capital investments, targeting high-quality enterprises with global potential [4] Leadership Background - Mr. Jingkai Li holds an executive master's degree in business administration from Macau University of Science and Technology and has over a decade of experience in the green industry [2] - He previously led Guangxi Qinyuan Environmental Protection Co., Ltd., where he built a technology-driven environmental protection industrial group, gaining expertise in operational management and industrial integration [2] - Mr. Li's experience includes strategic investments in new energy and smart technology sectors, positioning him as an ideal leader for Maase's growth [2] Strategic Vision - Mr. Li expressed his commitment to leveraging his experience in the green industry and strategic investment to foster innovation across Maase's business units [3] - The company has shown significant potential in areas such as smart car wash, energy storage batteries, and wellness businesses, which Mr. Li aims to capitalize on [3]

Core Viewpoint - Rakovina Therapeutics Inc. has announced the extension of the maturity date for its 12.0% convertible debentures from November 29, 2025, to January 28, 2026, following consent from debentureholders representing at least 66 2/3% of the outstanding principal [1][2] Group 1: Convertible Debentures - The total principal amount of the convertible debentures is $1,454,000.00, and the interest rate will remain at 12.0% during the extension period [1][2] - The extension is subject to approval from the TSX Venture Exchange [2] Group 2: Related Party Disclosure - Certain directors of the company own approximately $100,000 principal amount of the convertible debentures, representing about 6.9% of the outstanding principal [3] - The participation of these directors in the extension is classified as a "related party transaction" under applicable regulations, and the company has relied on exemptions from formal valuation and minority shareholder approval requirements [3] Group 3: Warrant Incentive Program - The company's early exercise warrant incentive program expired on September 2, 2025, with no warrants being exercised [4] Group 4: Company Overview - Rakovina Therapeutics is focused on developing innovative cancer treatments using AI-powered technologies for targeting DNA-damage response [5][6] - The company aims to advance one or more drug candidates into human clinical trials in collaboration with pharmaceutical partners [6]

Core Points - Algernon Health Inc. has closed the second tranche of its non-brokered private placement, raising gross proceeds of CAD $210,000 from the sale of 3,000,000 units at an issue price of CAD $0.07 per unit [2][3] - The funds raised will be utilized to advance the company's Alzheimer's Disease program, including the opening of its first U.S. Alzheimer's Disease clinic, as well as for general administrative expenses and working capital [3] - The securities issued are subject to a statutory hold period of four months plus a day from the date of issuance in accordance with Canadian securities legislation [4] Company Overview - Algernon Health is a Canadian healthcare company focused on providing brain-optimized PET scanning services for early-stage detection of Alzheimer's Disease and other neurological conditions [6] - The company has established a private subsidiary, Algernon USA LLC, to oversee its U.S. neuroimaging operations [6]

Core Insights - PharmaCorp RX Inc. reported strong operational momentum and financial performance for Q3 2025, driven by increased revenues, improved margins, and better operating efficiencies [2][4] - The company completed acquisitions of three pharmacies, enhancing its national presence and supporting its coast-to-coast ambitions [2][6][7] - Same-store sales increased by 9.4% year-over-year, and total prescription volumes rose by 7.2% compared to Q3 2024, indicating sustained growth in patient engagement [9] Financial Highlights - The reported net loss for the quarter reflects investments in corporate infrastructure and one-time legal fees related to obtaining a credit facility [5][9] - The company raised approximately C$23.0 million through a bought deal public offering, selling 54,855,000 units at C$0.42 per unit [8] - Solid pharmacy-level contribution margins and a disciplined approach to EBITDA multiples across acquisitions support PharmaCorp's long-term growth model [9] Operational Update - Key investments were made in systems, personnel, and integration processes to facilitate scalable national growth [5] - The company operates seven PharmaChoice Canada bannered pharmacies and aims to acquire more pharmacies, rebranding them under the PharmaChoice Canada platform [12]

Core Points - Spirit Blockchain Capital Inc. has filed its interim financial statements for the three and nine months ended September 30, 2025, in compliance with Canadian Securities Exchange requirements [1] - Lewis Bateman has been appointed as Interim Chief Financial Officer following the departure of Inder Saini [2] - Spirit Blockchain Capital focuses on developing blockchain-based financial infrastructure, including tokenization platforms and digital-asset services, aiming to generate recurring revenue [3]

Executive Transition - PharmaCorp RX Inc. announced the appointment of Paul Dale as President and Chief Operating Officer effective December 1, 2025, as Calvin LeRoux transitions to a one-year role as Strategic Advisor to the CEO [1][2] - Paul Dale has been with PharmaCorp since its inception as Chief Operating Officer and will now take on broader leadership responsibilities to support the company's national expansion strategy [2] - Calvin LeRoux will assist in the transition and continue to provide guidance on strategic initiatives and matters related to PharmaChoice Canada in his new advisory role [2] New Appointment - Sophia Sigler will join PharmaCorp as Director of Business Development effective December 1, 2025, leading business development initiatives, including sourcing acquisition opportunities and managing the transaction pipeline [2] Company Overview - PharmaCorp is a Canadian pharmacy acquisition and ownership platform focused on empowering pharmacists as equity partners and supporting succession for retiring pharmacy owners [3] - The company operates seven PharmaChoice Canada bannered pharmacies and aims to acquire both bannered and independent pharmacies across Canada, rebranding non-bannered locations under the PharmaChoice Canada platform [3]

TORONTO, Nov. 28, 2025 (GLOBE NEWSWIRE) -- ThreeD Capital Inc. (“ThreeD” or the “Company”) (CSE:IDK / OTCQX:IDKFF) a Canadian-based venture capital firm focused on opportunistic investments in companies in the junior resources and disruptive technologies sectors, is pleased to announce its unaudited quarterly results as at and for the three months September 30, 2025. As at September 30, 2025, the Company had cash, investments and digital assets of $26.5 million. As at September 30, 2025, net asset value per ...